-- （更正标题） 拜耳（BAYN.F）达成协议，将以最高24.5亿美元的价格收购美国生物制药公司Perfuse Therapeutics。Perfuse Therapeutics专注于眼科疾病的治疗。 根据周三发布的消息，根据拟议的交易条款，这家德国生命科学集团将向Perfuse Therapeutics支付3亿美元的首付款，并根据里程碑事件支付后续款项。 拜耳将获得PER-001的全部权益。PER-001是一种在研的小分子内皮素受体拮抗剂，用于治疗眼科疾病。该药物目前正处于中期临床开发阶段，有望成为治疗青光眼和糖尿病视网膜病变的疗法。 拜耳制药业务发展与许可负责人尤尔根·埃克哈特表示：“通过此次收购，我们将增强我们在眼科领域的专业知识和产品线，并进一步巩固我们致力于为患者开发急需疗法的承诺。”他强调了这款在研药物的潜力。 Perfuse Therapeutics 首席执行官兼创始人塞夫吉·古尔坎也表达了类似的观点，并指出该公司的愿景与拜耳高度契合。“他们拥有足够的规模和全球资源，能够充分发挥 PER-001 的潜力，从而改变人类失明的命运。” 此次收购预计将在获得必要的监管机构和 Perfuse 股东批准后生效。 截至周三中午，拜耳股票在德国 Xetra 交易所的交易价格上涨超过 2%。
Related Articles
Mining & Metals
Copper Lake Resources to Launch 20-For-1 Reverse Stock Split
Copper Lake Resources (CPL.V) intends to consolidate its common shares on the basis of 20 pre-consolidation common shares for every one post-consolidation common share effective as of May 8, it said Wednesday.The company currently has 271-million common shares issued and outstanding, and following the consolidation, the company will have about 13.6-million common shares issued and outstanding, prior to rounding for fractional shares.Its outstanding options of 19.5-million and warrants of 15.9-million will also be adjusted on the same basis as the common shares with proportionate adjustments being made to exercise prices.Shares of the company were last seen unchanged at $0.02 on the TSX Venture Exchange.
$CPL.V
Sectors
US Total Crude Oil Stocks Fall in Week Ended May 1
US crude oil stocks, including those in the Strategic Petroleum Reserve, fell by 7.5 million barrels in the week ended May 1 following a decrease of 13.4 million barrels in the previous week.Excluding inventories in the SPR, commercial crude oil stocks decreased by 2.3 million barrels after a 6.2-million-barrel drop in the previous week, compared with the 3.4-million-barrel decrease expected in a survey compiled by Bloomberg as of 7:35 am ET.Stocks in the SPR declined by 5.2 million in the week after falling by 7.1 million in the previous week.Overall crude oil stocks were down 0.9% from the previous week but were still up 1.5% from a year earlier. Crude oil inventories are about 1% above the five-year average for this time of year.Gasoline stocks declined by 2.5 million barrels, compared with the 2.6-million-barrel decrease expected. Gasoline stocks edged lower by 1.1% from the previous week and 2.6% from a year earlier.Distillate stocks dropped by 1.3 million barrels in the current week, compared with an expected decrease of 2.3 million barrels. Distillate stocks were down 1.2% from the previous week and 4.1% lower than in the same week a year ago.Refineries operated at 90.1% of their capacity, up from 89.6% in the previous week.
Research
Research Alert: L: Q1 Revenue And Eps Miss, Though Results May Not Be Comparable To Consensus
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:L's Q1 revenue of CAD14.4B (+4% Y/Y) missed consensus by CAD90M, while adjusted EPS of CAD0.49 (+9% Y/Y) fell short of CAD0.52 estimates, though we think PC Financial's presentation in discontinued operations may affect comparability. Food retail same-store sales of 2.4% accelerated from Q4's 1.5%, with drug retail posting 4.1% growth. We view the solid same-store sales momentum as encouraging, particularly given internal food inflation remained well below the 4.4% CPI, indicating L's strong value proposition. Management reiterated 2026 guidance for high single-digit EPS growth and CAD2.4B in gross capex. Store expansion accelerated with 13 net openings, including five hard discount locations, aligning with consumer preference shifts toward value formats. Strong FCF of CAD621M (+189% Y/Y) supported aggressive share repurchases of CAD648M. We believe the pending PC Financial divestiture in Q3 2026 will simplify operations and provide additional capital flexibility for core retail growth.
$L